|
US2009285840A1
|
|
Methods for treating pathological neovascularization
|
|
US2009142769A1
|
|
Methods for determining anti-TNF therapeutic response
|
|
US2009203006A1
|
|
Biological markers of chronic wound tissue and methods of using for criteria in surgical debridement
|
|
WO2007012068A2
|
|
Device for movement detection, movement correction and training
|
|
US2006149266A1
|
|
Anchor for screw fixation of soft tissue to bone
|
|
WO2006047728A2
|
|
Bmp gene and fusion protein
|
|
US2005263159A1
|
|
Radiofrequency ablation epiphysiodesis
|
|
US2005171199A1
|
|
Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents
|
|
US2004076663A1
|
|
Complexed-acidic-phospholipid-collagen composites for bone induction
|
|
US2003165578A1
|
|
Regulation of wound healing by nitric oxide
|
|
AU2003215165A8
|
|
Fcgammariib polymorphisms detection in system lupus erythematosus
|
|
CA2268332A1
|
|
Spinal positioning and support device
|
|
US6592538B1
|
|
Dynamic orthopedic braces
|
|
CA2271243A1
|
|
Diagnostic methods using cd40 ligand assay
|
|
CA2257197A1
|
|
Fc receptor polymorphism
|
|
US6190704B1
|
|
Regulation of wound healing by nitric oxide
|
